Vivanza Biosciences Ltd — Updates, 14-07-2025: Company Update

Vivanza Biosciences Limited has confirmed that it has not raised any new funds through public, rights, or preferential issues. Consequently, the company is not required to file a statement detailing any deviation or variation in the use of fund proceeds, as this specific reporting requirement is currently not applicable to them. This update assures investors of the company's current status regarding capital raises and reflects a routine compliance disclosure to the stock exchange.